Controlled Clinical Trial of Prophylactic Human-Leukocyte Interferon in Renal Transplantation

Abstract
A double-blind, placebo-controlled trial of interferon prophylaxis against viral infections was conducted in renal-transplant recipients receiving standard immunosuppressive therapy with or without antithymocyte globulin. Interferon was administered for six weeks, beginning on the day of transplantation.